Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial Ruby Khatun Khatun1 Dec 2017 9:30 AM ISTFRANKFURT: Germany's Merck KGaA has suffered a setback in the development of key cancer immunotherapy Bavencio, it has failed in a trial to prolong...
Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTZURICH: Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker...
FDA OKs Merck drug that prevents infection post-stem cell transplant Ruby Khatun Khatun11 Nov 2017 10:01 AM ISTMerck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug...
Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales Ruby Khatun Khatun11 Nov 2017 9:30 AM ISTRegeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand...
Merck cyber attack may cost insurers 275 million dollars: Verisks PCS Ruby Khatun Khatun23 Oct 2017 9:57 AM ISTNEW YORK: Insurers could pay $275 million to cover the insured portion of drugmaker Merck & Co's loss from a cyber attack in June, according to a...
Police raid French HQ of pharma giant Merck Ruby Khatun Khatun5 Oct 2017 9:49 AM ISTParis: Police on Tuesday raided the French headquarters of German pharmaceutical giant Merck, the maker of a thyroid drug at the center of a medical...
Merck to stop development of hepatitis C treatments Ruby Khatun Khatun4 Oct 2017 10:20 AM ISTU.S. drugmaker Merck & Co said on Friday it would discontinue developing an experimental drug combination for chronic hepatitis C, as competition...
German Merck hires JP Morgan to sell consumer health Ruby Khatun Khatun11 Sept 2017 9:57 AM ISTFRANKFURT/LONDON: Germany's Merck KGaA has hired JP Morgan to sell its consumer health business, which includes brands such as Seven Seas vitamins and...
Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in Immuno-Oncology Ruby Khatun Khatun9 Sept 2017 9:57 AM ISTKENILWORTH, N.J. & MUNICH: Merck, known as MSD outside the United States and Canada, and Rigontec announced that Merck will acquire...
